Eduardo Miguel Castaño
Eduardo Miguel Castaño publishes mostly in Physiology, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Alzheimer's disease research and treatments, Amyloidosis: Diagnosis, Treatment, Outcomes and Prion Diseases and Protein Misfolding.
- World rank
- #664,688 of 7,710,434 ranked researchers
- Rank in Argentina
- #799 of 38,473
- Works
- 93
- Citations
- 6.4k
- Citations per work
- 68.3
What does Eduardo Miguel Castaño research?
Eduardo Miguel Castaño's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (24%), Neuroscience (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3538.1%
- Medicine3538.1%
- Life Sciences3132.9%
- Everything else2729.0%
- 1Physiology31% of their works
- 2Molecular Biology24% of their works
- 3Cellular and Molecular Neuroscience5% of their works
- 4Neurology4% of their works
- 5Neurology4% of their works
- 6Pharmacology4% of their works
Research topics
- Alzheimer's disease research and treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Prion Diseases and Protein Misfolding
- Cholinesterase and Neurodegenerative Diseases
- Dementia and Cognitive Impairment Research
- Neuroinflammation and Neurodegeneration Mechanisms
- Computational Drug Discovery Methods
- Endoplasmic Reticulum Stress and Disease
Which keywords describe Eduardo Miguel Castaño's research?
The keywords of their largest research topics: Neurodegeneration, Neuroinflammation, Oxidative Stress, Amyloid Hypothesis, Tau Pathology, Neurodegenerative Diseases, Alzheimer's Disease and Cardiac Amyloidosis.
- Endoplasmic Reticulum
- Molecular Docking
- Astrocytes
- Dementia
- Acetylcholinesterase
- Molecular Basis
- Cardiac Amyloidosis
- Neurodegenerative Diseases
- Amyloid Hypothesis
- Neuroinflammation
- Neurodegeneration
- Oxidative Stress
- Tau Pathology
- Alzheimer's Disease
- Transthyretin
- Prion Diseases
- Cholinesterase Inhibitors
- Mild Cognitive Impairment
- Microglia
- Virtual Screening
- Stress
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Neurodegeneration822 topics
- Neuroinflammation822 topics
- Oxidative Stress782 topics
- Amyloid Hypothesis741 topic
- Tau Pathology741 topic
- Neurodegenerative Diseases212 topics
- Alzheimer's Disease182 topics
- Cardiac Amyloidosis161 topic
- Transthyretin161 topic
- Molecular Basis121 topic
- Prion Diseases121 topic
- Acetylcholinesterase91 topic
- Cholinesterase Inhibitors91 topic
- Dementia91 topic
- Mild Cognitive Impairment91 topic
- Astrocytes81 topic
- Microglia81 topic
- Molecular Docking81 topic
- Virtual Screening81 topic
- Endoplasmic Reticulum41 topic
- Stress41 topic
Where does Eduardo Miguel Castaño work?
Eduardo Miguel Castaño's main affiliation in the publication record is Fundación Instituto Leloir, Argentina.
How many publications and citations does Eduardo Miguel Castaño have?
OpenAlex counts 93 works and 6,356 citations for Eduardo Miguel Castaño, an h-index of 37, ranking #664,688 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Eduardo Miguel Castaño. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.